Native osteoprotegerin gene transfer inhibits the development of murine osteolytic bone disease induced by tumor xenografts
- 30 April 2004
- journal article
- research article
- Published by Elsevier in Experimental Hematology
- Vol. 32 (4) , 351-359
- https://doi.org/10.1016/j.exphem.2004.01.006
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myelomaBlood, 2001
- The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone ResorptionJournal of Bone and Mineral Research, 2000
- Osteoclastogenesis Inhibitory Factor (OCIF) Directly Inhibits Bone-Resorbing Activity of Isolated Mature OsteoclastsBiochemical and Biophysical Research Communications, 1998
- Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoidsJournal of Endocrinology, 1998
- Osteoclast Differentiation Factor (ODF) Induces Osteoclast-like Cell Formation in Human Peripheral Blood Mononuclear Cell CulturesBiochemical and Biophysical Research Communications, 1998
- Osteoclast Differentiation Factor Mediates an Essential Signal for Bone Resorption Induced by 1α,25-Dihydroxyvitamin D3, Prostaglandin E2, or Parathyroid Hormone in the Microenvironment of BoneBiochemical and Biophysical Research Communications, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Establishment and Characterization of an Immortal Macrophage-like Cell Line Inducible to Differentiate to OsteoclastsBiochemical and Biophysical Research Communications, 1998
- Hypercalcemia of malignancy revisited.Journal of Clinical Investigation, 1988
- Production of Lymphotoxin, a Bone-Resorbing Cytokine, by Cultured Human Myeloma CellsNew England Journal of Medicine, 1987